A phase III, randomized, double-dummy, double blind, misoprostol-comparative clinical trial to evaluate the efficacy and safety of Mucosta [rebamipide] tablet in the prevention of NSAID [nonsteroidal anti-inflammatory drugs]-induced gastrointestinal complications.

Trial Profile

A phase III, randomized, double-dummy, double blind, misoprostol-comparative clinical trial to evaluate the efficacy and safety of Mucosta [rebamipide] tablet in the prevention of NSAID [nonsteroidal anti-inflammatory drugs]-induced gastrointestinal complications.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Sep 2016

At a glance

  • Drugs Rebamipide (Primary) ; Misoprostol
  • Indications NSAID-induced ulcer
  • Focus Registrational; Therapeutic Use
  • Acronyms PRESENT
  • Sponsors Korea Otsuka Pharmaceutical
  • Most Recent Events

    • 15 Nov 2011 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
    • 15 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 10 May 2011 Results presented at Digestive Disease Week 2011.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top